Global Rank
#27809
Country Rank
n/a
Market Cap
61.68 M
Price
2.27
Change (%)
0.64%
Volume
53,080
CHA Vaccine Research Institute's latest marketcap:
61.68 M
As of 06/06/2025, CHA Vaccine Research Institute's market capitalization has reached $61.68 M. According to our data, CHA Vaccine Research Institute is the 27809th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 61.68 M |
| Revenue (ttm) | -0.01 |
| Net Income (ttm) | -8,245,320.47 |
| Shares Out | 26.87 M |
| EPS (ttm) | -0.31 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 06/06/2025
CHA Vaccine Research Institute's yearly market capitalization.
CHA Vaccine Research Institute has seen its market value drop from ₩293.36 B to ₩84.49 B since 2021, representing a total decrease of 71.20% and an annual compound decline rate (CAGR) of 30.39%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₩84.49 B | 2.93% |
| 12/30/2024 | ₩82.08 B | -45.65% |
| 12/28/2023 | ₩151.04 B | 14.64% |
| 12/29/2022 | ₩131.75 B | -55.09% |
| 12/30/2021 | ₩293.36 B |
Company Profile
About Cha Vaccine Research Institute Co., Ltd.
Cha Vaccine Research Institute Co., Ltd. is a research-driven biotechnology company specializing in the development of vaccines for infectious and chronic diseases. Founded in 2000 and headquartered in Seongnam, South Korea, the company is dedicated to advancing innovative vaccine solutions.
Product Pipeline
- HBV Vaccine – Currently in Phase IIb planning for hepatitis B prevention.
- Adjuvanted HBV Vaccine – In Phase I/IIa for the treatment of chronic hepatitis B.
- VZV Vaccine – In pre-clinical planning stage for Herpes Zoster prevention.
Additional Developments
The company is also actively working on:
- Influenza vaccine
- Recombinant MBL
- TB vaccine
- Cancer vaccine
Frequently Asked Questions
-
What is CHA Vaccine Research Institute's (KOSDAQ-261780) current market cap?As of 06/06/2025, CHA Vaccine Research Institute (including the parent company, if applicable) has an estimated market capitalization of $61.68 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CHA Vaccine Research Institute (KOSDAQ-261780) rank globally by market cap?CHA Vaccine Research Institute global market capitalization ranking is approximately 27809 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.